Publications by authors named "Ricky Hsu"

Claim this Profile
C
Comparable real-world effectiveness between switches to cabotegravir + rilpivirine long-acting or modern daily oral regimens in the United States: an OPERA cohort study.
Ricky K Hsu, Michael G Sension, Jennifer S Fusco, Laurence Brunet, Quateka Cochran

J Int AIDS Soc· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir interruption among people with HIV and HBV: HBV monitoring and risk of HBV reactivation and hepatitis flare.
Douglas T Dieterich, Laurence Brunet, Ricky K Hsu, Karam Mounzer, Gerald Pierone

AIDS· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide.
Karam Mounzer, Michael D Osterman, Laurence Brunet, Ricky K Hsu, Gerald Pierone

AIDS Res Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight loss with real-world doravirine use in the OPERA cohort: a US-based cohort study.
Karam Mounzer, Laurence Brunet, Michael Sension, Ricky K Hsu, Michael D Osterman

AIDS Res Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study.
Ricky K Hsu, Laurence Brunet, Philip C Lackey, Gerald Pierone, Brooke Levis

HIV Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART Era.
Michael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, Javeed Siddiqui, Michael Harbour, Ricky K Hsu

AIDS Res Hum Retroviruses· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Adherence to the Target Window for Cabotegravir + Rilpivirine Long-Acting Injections Through the CHORUS™ App and Web Portal: A Cluster Randomized Trial.
Michael B Wohlfeiler, Laurence Brunet, Quateka Cochran, Jennifer S Fusco, Ricky K Hsu

J Int Assoc Provid AIDS Care· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA Cohort.
Michael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, Javeed Siddiqui, Michael Harbour, Ricky K Hsu

AIDS Res Hum Retroviruses· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort.
Michael G Sension, Laurence Brunet, Ricky K Hsu, Jennifer S Fusco, Quateka Cochran

Infect Dis Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes.
Ricky K Hsu, Jennifer S Fusco, Cassidy E Henegar, Vani Vannappagari, Andrew Clark

BMC Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excessive Weight Gain: Current Antiretroviral Agents in Virologically Suppressed People with HIV.
Ricky K Hsu, Laurence Brunet, Jennifer S Fusco, Karam Mounzer, Joyce C Lamori

AIDS Res Hum Retroviruses· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Body Mass Index Associated with Antiretroviral Regimen Switch Among Treatment-Experienced, Virologically Suppressed People Living with HIV in the United States.
Karam Mounzer, Laurence Brunet, Ricky Hsu, Jennifer Fusco, Vani Vannappagari

AIDS Res Hum Retroviruses· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort.
Karam C Mounzer, Jennifer S Fusco, Ricky K Hsu, Laurence Brunet, Vani Vannappagari

AIDS Patient Care STDS· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing bias introduced in estimated glomerular filtration rate by the inhibition of creatinine tubular secretion from common antiretrovirals.
Laurence Brunet, Christina Wyatt, Ricky Hsu, Karam Mounzer, Jennifer Fusco

Antivir Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To dose-adjust or not to dose-adjust: lamivudine dose in kidney impairment.
Karam Mounzer, Laurence Brunet, Christina M Wyatt, Jennifer S Fusco, Vani Vannappagari, Ricky K Hsu

AIDS· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight gain before and after switch from TDF to TAF in a U.S. cohort study.
Patrick Wg Mallon, Laurence Brunet, Ricky K Hsu, Jennifer S Fusco, Karam C Mounzer

J Int AIDS Soc· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs.
Ricky Hsu, Laurence Brunet, Jennifer S Fusco, Karam Mounzer, Vani Vannappagari

AIDS· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral therapy and liver disorders in the OPERA cohort.
Michael Wohlfeiler, Karam Mounzer, Laurence Brunet, Jennifer Fusco, Vani Vannappagari, Ricky Hsu

Ther Adv Drug Saf· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA-B*5701 Screening as a Risk-Mitigation Measure.
Chris M Stainsby, Teodora M Perger, Vani Vannappagari, Karam C Mounzer, Ricky K Hsu

Pharmacotherapy· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA observational database: a cohort study.
Karam Mounzer, Ricky Hsu, Jennifer S Fusco, Laurence Brunet, Cassidy E Henegar

AIDS Res Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis database.
Ricky Hsu, Jennifer Fusco, Cassidy Henegar, Karam Mounzer, Michael Wohlfeiler

Ther Adv Drug Saf· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice.
Philip Lackey, Anthony Mills, Felix Carpio, Ricky Hsu, Edwin DeJesus

Clin Drug Investig· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection.
Daniel S Fierer, Douglas T Dieterich, M Isabel Fiel, Andrea D Branch, Kristen M Marks, Ricky Hsu

Clin Infect Dis· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.

Science· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis